At a glance
- Originator Nonindustrial source
- Class Prostaglandins; Small molecules
- Mechanism of Action Molecular chaperone GRP78 protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 27 Nov 2000 Preclinical development for Alzheimer's disease in Japan (Unknown route)